epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Dilantin
    phenytoin
  • remove Dyanavel XR
    amphetamine

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Dilantin (phenytoin) + Dyanavel XR (amphetamine)

Caution Advised


phenytoin + amphetamine

caution advised: combo may alter seizure control; may decr. peak phenytoin levels, efficacy (antagonistic effects, amphetamine may decr. seizure threshold; absorption possibly delayed)

Additional Considerations

Smiley face Smiley face amphetamine in Dyanavel XR

add MAO inhibitor to Interaction Check if recent (14 days) use

avoid combo with beverages or products containing ethanol and Adzenys XR-ODT, Dyanavel XR, Mydayis, generic extended-release orally disintegrating tablet (ER ODT) formulations; combo may incr. amphetamine release rate, levels, risk of adverse effects, decr. duration of efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information